|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.149 SEK | -4.79% |
|
-14.86% | -78.56% |
| 23/04 | Spermosens AB Appoints Tore Duvold as CEO, Effective May 1, 2024 | CI |
| 09/02 | Spermosens AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Spermosens AB reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 11.25 million compared to SEK 12.49 million a year ago. Revenue was SEK 11.67 million compared to SEK 13.06 million a year ago.
Net loss was SEK 12.65 million compared to SEK 6.42 million a year ago. Basic loss per share from continuing operations was SEK 1.1 compared to SEK 0.73 a year ago.
SPERMOSENS AB